A carregar...
PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer
Aims: PARK2 mutation is originally associated with the progression of Parkinson's disease. In recent years, PARK2 has been reported as a tumor suppressor gene in various cancers, including lung cancer. However, the biological functions and potential molecular mechanisms of PARK2 in non-small ce...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6716169/ https://ncbi.nlm.nih.gov/pubmed/31508359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00790 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|